General Electric’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-2,676,658
Closed -$619M 192
2016
Q2
$619M Buy
2,676,658
+322,108
+14% +$74.3M 3.22% 2
2016
Q1
$631M Buy
2,354,550
+97,000
+4% +$27.8M 3.23% 2
2015
Q4
$705M Buy
2,257,550
+34,846
+2% +$10.4M 3.41% 2
2015
Q3
$604M Sell
2,222,704
-57,992
-3% -$17.8M 1.44% 3
2015
Q2
$692M Buy
2,280,696
+101,382
+5% +$30.2M 1.55% 3
2015
Q1
$649M Buy
2,179,314
+2,357
+0.1% +$672K 1.51% 3
2014
Q4
$560M Buy
2,176,957
+239,649
+12% +$59.9M 1.31% 5
2014
Q3
$467M Buy
1,937,308
+963,306
+99% +$216M 1.21% 7
2014
Q2
$217M Buy
974,002
+240,948
+33% +$49.9M 0.99% 34
2014
Q1
$151M Buy
733,054
+26,811
+4% +$5.31M 0.71% 53
2013
Q4
$119M Sell
706,243
-152,675
-18% -$23.9M 0.56% 60
2013
Q3
$124M Sell
858,918
-37,493
-4% -$4.99M 0.62% 52
2013
Q2
$113M Buy
+896,411
New +$101M 0.59% 54

Other funds holding AGN

General Electric's AGN Position: Q3 2016 in Review

General Electric sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 2,676,658 shares — an estimated $619M sold.

General Electric first reported a position in AGN in Q2 2013 and held it in 13 quarters. The position peaked at $705M in Q4 2015. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • General Electric reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • General Electric sold 2,676,658 Allergan plc shares in Q3 2016, an estimated $619M.
  • General Electric first reported a position in Allergan plc in Q2 2013 and held it in 13 quarters.
  • General Electric's Allergan plc position peaked at $705M in Q4 2015.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on General Electric's 13F filing for Q3 2016, filed 10 Nov 2016.